Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Pharmaceutical

Key Companies in the Pericarditis Market

Pericarditis is a medical condition characterized by inflammation of the pericardium, the thin sac-like membrane surrounding the heart. This inflammation can lead to chest pain, fever, and other symptoms, making it a critical condition that requires prompt diagnosis and treatment.

Report ID: MRFR/Pharma/1315-CR | Pages: 156 | Author: Nidhi Mandole, Rahul Gotadki | Updated: February 16, 2025
Request Free Sample
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Pericarditis Market

Pericarditis Key Companies
 
Latest Pericarditis Companies Update:

R-Pharm International LLC announces positive Phase IIb results for CardiolRx: This investigational new drug for recurrent pericarditis demonstrates potential for long-term disease control and reduced risk of recurrence.

Cardiol Therapeutics acquires PerImmune to advance development of CardiolRx: This acquisition strengthens CardiolRx's clinical development program and expands its focus on treating recurrent pericarditis.

Abbott Laboratories partners with Inovio Pharmaceuticals to develop DNA vaccine for pericarditis: This collaboration aims to prevent pericarditis associated with viral infections or autoimmune diseases.

List of Pericarditis Key companies in the market
  • Pfizer Inc.
  • AstraZeneca Plc
  • Novartis International AG
  • Allergan plc.
  • and Merck & Co., Inc.
  • Bayer AG
  • Reckitt Benckiser Group Plc.
  • PerkinElmer, Inc.
  • FUJIFILM Holdings Corporation
  • Sanofi
  • Johnson & Johnson Services